Kamada Ltd. Logo

Kamada Ltd.

A biopharmaceutical company specializing in plasma-derived protein therapeutics.

KMDA | TA

Overview

Corporate Details

ISIN(s):
IL0010941198
LEI:
Country:
Israel
Address:
2 Holzman St, Science Park, 7670402 Rehovot

Description

Kamada Ltd. is a vertically integrated global biopharmaceutical company specializing in plasma-derived protein therapeutics. The company develops, manufactures, and commercializes a portfolio of products for rare and serious conditions, with a focus on therapeutic areas such as Alpha-1 Antitrypsin Deficiency (AATD) and Cytomegalovirus (CMV) prevention in transplant patients. Kamada utilizes a proprietary platform technology for advanced protein extraction and purification from human plasma. In addition to its marketed products, the company maintains a development pipeline of new therapies, including an inhaled treatment for AATD.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-14 16:00
Kamada Reports Strong First Quarter 2025 Financial Results with Year Over Year …
English 8.4 MB
2025-05-14 16:00
Kamada Reports Strong First Quarter 2025 Financial Results with Year Over Year …
English 36.5 KB
2025-05-07 16:00
Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025
English 151.4 KB
2025-05-07 16:00
Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025
English 36.3 KB
2025-05-05 16:00
Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for …
English 178.4 KB
2025-05-05 16:00
Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for …
English 36.5 KB
2025-03-24 14:04
Kamada Updates on Withholding Tax Procedures on Previously Announced Special Ca…
English 146.0 KB
2025-03-24 14:04
Kamada Updates on Withholding Tax Procedures on Previously Announced Special Ca…
English 36.4 KB
2025-03-19 14:00
Kamada Announces Expansion of Plasma Collection Operations with the Opening of …
English 181.2 KB
2025-03-19 14:00
Kamada Announces Expansion of Plasma Collection Operations with the Opening of …
English 36.5 KB
2025-03-05 15:10
20F Annual filing 2024
English 2.1 MB
2025-03-05 15:10
20F Annual filing 2024
English 36.5 KB
2025-03-05 15:05
financial results for the three months and year ended December 31, 2024
English 4.7 MB
2025-03-05 15:05
financial results for the three months and year ended December 31, 2024
English 36.5 KB
2025-02-26 15:00
Fourth Quarter and Fiscal Year 2024 Financial Results and conference call on Ma…
English 187.8 KB

Automate Your Workflow. Get a real-time feed of all Kamada Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kamada Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kamada Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Annexon, Inc. Logo
Clinical-stage biopharma developing complement medicines by inhibiting C1q.
United States of America
ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes cell therapies and orphan drugs using adult stem cells.
South Korea
065660
Antibiotice S.A. Logo
Pharmaceutical firm manufacturing generic medicines, anti-infectives, and APIs.
Romania
ATB
Apellis Pharmaceuticals, Inc. Logo
Biopharmaceutical company developing therapies by targeting the complement cascade.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Clinical-stage biopharma developing a bee venom drug and AI digital treasury solutions.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Clinical-stage biotech developing biologics for immunological and inflammatory diseases.
United States of America
APGE
Apollomics Inc. Logo
Clinical-stage biotech developing innovative oncology and combination therapies.
United States of America
APLM
Apontis Pharma AG Logo
Develops and markets fixed-dose combination drugs (Single Pills) for chronic diseases.
Germany
APPH
Applied Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel drugs for rare metabolic and CNS diseases.
United States of America
APLT
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologics and biosimilar antibody-based therapeutics.
South Korea
003060

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.